Relizorb
Payments companies reported to CMS as associated with Relizorb. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Relizorb, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Relizorb
These are the largest totals companies reported as associated with Relizorb. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Recker | Libertyville, IL | Internal Medicine | $610,664.41 |
| Valeria Cohran | Chicago, IL | Pediatric Gastroenterology | $79,852.71 |
| Stephanie Abrams | Houston, TX | Pediatric Gastroenterology | $60,014.79 |
| Mary Abigail Garcia | San Diego, CA | Pediatric Gastroenterology | $44,515.58 |
| Candi Jump | Charleston, SC | Pediatric Gastroenterology | $42,842.62 |
| Akash Pandey | Orlando, FL | Pediatric Gastroenterology | $42,158.56 |
| Sivan Kinberg | New York, NY | Pediatric Gastroenterology | $35,646.65 |
| Beth Schrope | New York, NY | Surgery | $19,283.55 |
| Joseph Woolley | Phoenix, AZ | Pediatric Gastroenterology | $13,835.58 |
| David Evans | Columbus, OH | Trauma Surgery | $12,424.16 |
Prescribed Relizorb?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.